• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.

作者信息

Guglielmone H A, Vides M A

机构信息

Departamento de Bioquímica Clínica, Facultad de Ciencas Químicas, Universidad Nacional de Córdoba, Argentina.

出版信息

Ann Biol Clin (Paris). 1990;48(8):547-50.

PMID:2288441
Abstract

The objective of this report is to compare the prothrombin time performed with thromboplastin of different tissues and species in patients under oral anticoagulant therapy as well as the way of expressing the results. The results showed that the ISI of the thromboplastin of human and rabbit brain are very close to the IRP BCT/253 (1.2 vs 1.1) and RBT/79 (1.3 vs 1.4), respectively. In contrast, the rabbit lung thromboplastin showed the greatest differences in the ISI values (1.6 vs 1.4) and in the CV (6.1%). The authors found significant statistical differences with the results of the prothrombin time as expressed in activity percentage (p less than 0.001) in three plasma pools of patients under different oral anticoagulant level for all thromboplastins studied. However, if the results are expressed in terms of INR, the values obtained are almost the same. The results here reported would demonstrate that the prothrombin time as INR allows the use of only one scheme for oral anticoagulant control when the thromboplastin reagent is calibrated according to the recommendations of the WHO.

摘要

相似文献

1
Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
Ann Biol Clin (Paris). 1990;48(8):547-50.
2
[Prothrombin time and its standardization].[凝血酶原时间及其标准化]
Rinsho Byori. 2002 Aug;50(8):779-85.
3
[Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin].[凝血活酶导致的国际标准化比值(INR)变异性。两种重组凝血活酶与一种兔凝血活酶的比较]
Ann Biol Clin (Paris). 1995;53(6):353-6.
4
[Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].[抗维生素K治疗的生物学监测。国际标准化比值(INR)的价值及新治疗范围的定义。对73例患者的研究]
Arch Mal Coeur Vaiss. 1990 Mar;83(3):357-61.
5
[Quality control of ISI/INR system in oral anticoagulant therapy].[口服抗凝治疗中国际标准化比值(ISI)/国际标准化比率(INR)系统的质量控制]
Rinsho Ketsueki. 1990 Jun;31(6):769-75.
6
[Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination].[用于凝血酶原时间测定的敏感兔脑凝血活酶与人胎盘凝血活酶的比较]
Schweiz Med Wochenschr. 1989 Feb 11;119(6):178-83.
7
Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.口服抗凝治疗中凝血酶原时间标准化的可靠性及临床影响
Thromb Haemost. 1985 Feb 18;53(1):148-54.
8
Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
Thromb Haemost. 1994 Aug;72(2):261-7.
9
Standardization of coagulation tests.凝血试验的标准化。
Southeast Asian J Trop Med Public Health. 1999;30 Suppl 3:79-85.
10
Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.用于口服抗凝治疗实验室监测的凝血酶原时间标准化
Semin Thromb Hemost. 1999;25(1):17-25. doi: 10.1055/s-2007-996419.